Tokyo Tape
Sign in
← Muromachi Chemicals

Quarterly report · Q2

4885.TEDINET S100PYKH
Period2022-06-01 → 2022-11-30
Filed2023-01-13
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 51
MetricValuePeriodScopeSource row
Revenue¥3.1bn2022-06-01 → 2022-11-30StandaloneNet sales
Revenue¥5.7bn2021-06-01 → 2022-05-31StandaloneNet sales (5-year summary)
Revenue¥2.8bn2021-06-01 → 2021-11-30StandaloneNet sales
Operating income¥225m2022-06-01 → 2022-11-30StandaloneOperating income
Operating income¥323m2021-06-01 → 2021-11-30StandaloneOperating income
Ordinary income¥208m2022-06-01 → 2022-11-30StandaloneOrdinary income
Ordinary income¥423m2021-06-01 → 2022-05-31StandaloneOrdinary income loss (5-year summary)
Ordinary income¥324m2021-06-01 → 2021-11-30StandaloneOrdinary income
Profit before tax¥208m2022-06-01 → 2022-11-30StandaloneIncome before income taxes
Profit before tax¥324m2021-06-01 → 2021-11-30StandaloneIncome before income taxes
Net income¥149m2022-06-01 → 2022-11-30StandaloneProfit loss
Net income¥456m2021-06-01 → 2022-05-31StandaloneNet income loss (5-year summary)
Net income¥262m2021-06-01 → 2021-11-30StandaloneProfit loss
Total assets¥5.0bnat 2022-11-30StandaloneAssets
Total assets¥4.8bnat 2022-05-31StandaloneAssets
Total assets¥4.5bnat 2021-11-30StandaloneTotal assets (5-year summary)
Total liabilities¥3.2bnat 2022-11-30StandaloneLiabilities
Total liabilities¥3.1bnat 2022-05-31StandaloneLiabilities
Net assets / equity¥1.8bnat 2022-11-30StandaloneNet assets
Net assets / equity¥1.7bnat 2022-05-31StandaloneNet assets
Net assets / equity¥1.6bnat 2021-11-30StandaloneNet assets (5-year summary)
Cash and deposits¥765mat 2022-11-30StandaloneCash and deposits
Cash and deposits¥865mat 2022-05-31StandaloneCash and deposits
Cash & equivalents¥765mat 2022-11-30StandaloneCash and cash equivalents
Cash & equivalents¥865mat 2022-05-31StandaloneCash and cash equivalents
Cash & equivalents¥839mat 2021-11-30StandaloneCash and cash equivalents
Cash & equivalents¥1.0bnat 2021-05-31dStandaloneCash and cash equivalents
Operating cash flow−¥58m2022-06-01 → 2022-11-30StandaloneNet cash provided by used in operating activities
Operating cash flow¥525m2021-06-01 → 2022-05-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥152m2021-06-01 → 2021-11-30StandaloneNet cash provided by used in operating activities
Investing cash flow−¥69m2022-06-01 → 2022-11-30StandaloneNet cash provided by used in investment activities
Investing cash flow−¥176m2021-06-01 → 2022-05-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥56m2021-06-01 → 2021-11-30StandaloneNet cash provided by used in investment activities
Financing cash flow¥28m2022-06-01 → 2022-11-30StandaloneNet cash provided by used in financing activities
Financing cash flow−¥484m2021-06-01 → 2022-05-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥257m2021-06-01 → 2021-11-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥39.922022-06-01 → 2022-11-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥16.82022-09-01 → 2022-11-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥123.792021-06-01 → 2022-05-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥71.352021-06-01 → 2021-11-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥37.972021-09-01 → 2021-11-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥38.622022-06-01 → 2022-11-30StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥112.562021-06-01 → 2022-05-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥64.362021-06-01 → 2021-11-30StandaloneDiluted earnings per share (5-year summary)
Dividend per share¥192021-06-01 → 2022-05-31StandaloneDividend paid per share (5-year summary)
Equity ratio35.8%at 2022-11-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio35.0%at 2022-05-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio34.6%at 2021-11-30StandaloneEquity to asset ratio (5-year summary)
Shares issued4,095,500at 2022-11-30StandaloneTotal number of issued shares (5-year summary)
Shares issued4,095,500at 2022-05-31StandaloneTotal number of issued shares (5-year summary)
Shares issued4,095,500at 2021-11-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segmentrevenue2022-06-01 → 2022-11-30¥965m
jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segmentrevenue external2022-06-01 → 2022-11-30¥965m
jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segmentsegment profit2022-06-01 → 2022-11-30−¥20m
jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segmentrevenue2022-06-01 → 2022-11-30¥377m
jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segmentrevenue external2022-06-01 → 2022-11-30¥377m
jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segmentsegment profit2022-06-01 → 2022-11-30−¥39m
jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segmentrevenue2022-06-01 → 2022-11-30¥1.8bn
jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segmentrevenue external2022-06-01 → 2022-11-30¥1.8bn
jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segmentsegment profit2022-06-01 → 2022-11-30¥284m
—segment totalrevenue2022-06-01 → 2022-11-30¥3.1bn
—segment totalrevenue external2022-06-01 → 2022-11-30¥3.1bn
—segment totalsegment profit2022-06-01 → 2022-11-30¥225m
Total Of Reportable Segments And Otherssegment totalrevenue2022-06-01 → 2022-11-30¥3.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-06-01 → 2022-11-30¥3.1bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-06-01 → 2022-11-30¥225m
jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segmentrevenue2021-06-01 → 2021-11-30¥956m
jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segmentrevenue external2021-06-01 → 2021-11-30¥956m
jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segmentsegment profit2021-06-01 → 2021-11-30¥5m
jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segmentrevenue2021-06-01 → 2021-11-30¥488m
jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segmentrevenue external2021-06-01 → 2021-11-30¥488m
jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segmentsegment profit2021-06-01 → 2021-11-30¥40m
jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segmentrevenue2021-06-01 → 2021-11-30¥1.4bn
jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segmentrevenue external2021-06-01 → 2021-11-30¥1.4bn
jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segmentsegment profit2021-06-01 → 2021-11-30¥278m
—segment totalrevenue2021-06-01 → 2021-11-30¥2.8bn
—segment totalrevenue external2021-06-01 → 2021-11-30¥2.8bn
—segment totalsegment profit2021-06-01 → 2021-11-30¥323m
Total Of Reportable Segments And Otherssegment totalrevenue2021-06-01 → 2021-11-30¥2.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-06-01 → 2021-11-30¥2.8bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-06-01 → 2021-11-30¥323m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 495
ItemContextValueUnit
Short term loans payableCurrentQuarterInstant_NonConsolidatedMember600000000JPY
Current portion of long term loans payablePrior1YearInstant_NonConsolidatedMember202480000JPY
Current portion of long term loans payableCurrentQuarterInstant_NonConsolidatedMember216160000JPY
Income taxes payablePrior1YearInstant_NonConsolidatedMember25680000JPY
Income taxes payableCurrentQuarterInstant_NonConsolidatedMember35795000JPY
Provision for bonusesPrior1YearInstant_NonConsolidatedMember183383000JPY
Provision for bonusesCurrentQuarterInstant_NonConsolidatedMember185846000JPY
Other clPrior1YearInstant_NonConsolidatedMember276268000JPY
Other clCurrentQuarterInstant_NonConsolidatedMember199858000JPY
Current liabilitiesPrior1YearInstant_NonConsolidatedMember2225354000JPY
Current liabilitiesCurrentQuarterInstant_NonConsolidatedMember2134718000JPY
Long term loans payablePrior1YearInstant_NonConsolidatedMember783080000JPY
Long term loans payableCurrentQuarterInstant_NonConsolidatedMember968160000JPY
Provision for retirement benefitsPrior1YearInstant_NonConsolidatedMember18300000JPY
Provision for retirement benefitsCurrentQuarterInstant_NonConsolidatedMember18042000JPY
Provision for directors retirement benefitsPrior1YearInstant_NonConsolidatedMember60965000JPY
Provision for directors retirement benefitsCurrentQuarterInstant_NonConsolidatedMember－JPY
Asset retirement obligations nclPrior1YearInstant_NonConsolidatedMember26227000JPY
Asset retirement obligations nclCurrentQuarterInstant_NonConsolidatedMember26227000JPY
Long term accounts payable otherPrior1YearInstant_NonConsolidatedMember－JPY
Long term accounts payable otherCurrentQuarterInstant_NonConsolidatedMember56845000JPY
Other nclPrior1YearInstant_NonConsolidatedMember3063000JPY
Other nclCurrentQuarterInstant_NonConsolidatedMember2644000JPY
Noncurrent liabilitiesPrior1YearInstant_NonConsolidatedMember891636000JPY
Noncurrent liabilitiesCurrentQuarterInstant_NonConsolidatedMember1071919000JPY
LiabilitiesPrior1YearInstant_NonConsolidatedMember3116990000JPY
LiabilitiesCurrentQuarterInstant_NonConsolidatedMember3206638000JPY
Capital stockPrior1YearInstant_NonConsolidatedMember143172000JPY
Capital stockCurrentQuarterInstant_NonConsolidatedMember143172000JPY
Capital surplusPrior1YearInstant_NonConsolidatedMember685981000JPY
Capital surplusCurrentQuarterInstant_NonConsolidatedMember702618000JPY
Retained earningsPrior1YearInstant_NonConsolidatedMember952038000JPY
Retained earningsCurrentQuarterInstant_NonConsolidatedMember1030409000JPY
Treasury stockPrior1YearInstant_NonConsolidatedMember-109777000JPY
Treasury stockCurrentQuarterInstant_NonConsolidatedMember-102746000JPY
Shareholders equityPrior1YearInstant_NonConsolidatedMember1671415000JPY
Shareholders equityCurrentQuarterInstant_NonConsolidatedMember1773454000JPY
Valuation difference on available for sale securitiesPrior1YearInstant_NonConsolidatedMember9664000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant_NonConsolidatedMember14252000JPY
Valuation and translation adjustmentsPrior1YearInstant_NonConsolidatedMember9664000JPY
Valuation and translation adjustmentsCurrentQuarterInstant_NonConsolidatedMember14252000JPY
Net assetsPrior1YearInstant_NonConsolidatedMember1681080000JPY
Net assetsCurrentQuarterInstant_NonConsolidatedMember1787706000JPY
Liabilities and net assetsPrior1YearInstant_NonConsolidatedMember4798071000JPY
Liabilities and net assetsCurrentQuarterInstant_NonConsolidatedMember4994344000JPY
Net salesPrior1YTDDuration_NonConsolidatedMember2807947000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember3121245000JPY
Cost of salesPrior1YTDDuration_NonConsolidatedMember1852873000JPY
Cost of salesCurrentYTDDuration_NonConsolidatedMember2226884000JPY
Gross profitPrior1YTDDuration_NonConsolidatedMember955074000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2022-05-31pass rounding
balance sheet identitynon_consolidated 2022-11-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-05-31pass
statement vs summary · net assetsnon_consolidated 2022-11-30pass
statement vs summary · operating cash flownon_consolidated 2021-06-01/2021-11-30pass
statement vs summary · operating cash flownon_consolidated 2022-06-01/2022-11-30pass
statement vs summary · revenuenon_consolidated 2021-06-01/2021-11-30pass
statement vs summary · revenuenon_consolidated 2022-06-01/2022-11-30pass
statement vs summary · total assetsnon_consolidated 2022-05-31pass
statement vs summary · total assetsnon_consolidated 2022-11-30pass